Company Overview
ACADIA PHARMACEUTICALS INC
ACADRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1,072M
2025 FY
Net Income
391M
2025 FY
Shares Outstanding
168M
2025 FY
EPS
2.32USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1070494
Exchange
Nasdaq
Location
US